ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,925.99
      -0.75%
      US Tech 100
      20,731.20
      -0.82%
      Dow Jones
      42,666.14
      -0.76%
      Brent Oil
      74.275
      0.88%
      Bitcoin
      93,429.62
      -0.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Xeris Biopharma Holdings Inc (XERS) Quote

      Xeris Biopharma Holdings Inc

      Xeris Biopharma Holdings Inc (XERS)

      NASDAQ
      3.40
      -0.03
      ( -0.87% )
      Updated: 12:43:24
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.40
      Bid
      3.40
      Ask
      3.41
      Volume
      650,636
      3.2736 Day's Range 3.4053
      1.69 52 Week Range 3.87
      Market Cap
      506.877M
      Previous Close
      3.43
      Open
      3.40
      Last Trade
      25
      @
      3.4
      Last Trade Time
      12:43:24
      Financial Volume
      $ 2,168,875
      VWAP
      3.3335
      Average Volume (3m)
      1,571,654
      Shares Outstanding
      149,081,461
      Dividend Yield
      -
      PE Ratio
      -8.14
      Earnings Per Share (EPS)
      -0.42
      Revenue
      163.91M
      Net Profit
      -62.26M

      About Xeris Biopharma Holdings Inc

      Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.xerispharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was $3.43. Over the last year, Xeris Biopharma shares have traded in a share price range of $ 1.69 to $ 3.87.

      Xeris Biopharma currently has 149,081,461 shares outstanding. The market capitalization of Xeris Biopharma is $511.35 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -8.14.

      Ask ADVFN Intelligence (AI)

      XERS Latest News

      More News

      Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

      November 26 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 08 2024
      Edgar (US Regulatory)

      Xeris Biopharma Reports Third Quarter 2024 Financial Results

      Achieved record total revenue of $54.3M including record product revenue of $52.9M Product revenue increased 27% versus prior year and 14% over the prior quarter Ended Q3 with $69.4M in cash...

      November 08 2024
      Business Wire

      Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

      Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

      October 31 2024
      Business Wire

      Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

      October 04 2024
      Business Wire

      Xeris to Participate in Upcoming Investor Conferences

      Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

      August 22 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 09 2024
      Edgar (US Regulatory)

      Form S-8 - Securities to be offered to employees in employee benefit plans

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.07-2.017291066283.473.523.273610069053.44184471CS
      40.113.343465045593.293.873.1716982463.47176986CS
      120.4113.71237458192.993.872.7315716543.27929689CS
      261.1651.78571428572.243.872.0315409192.92198132CS
      521.0947.18614718612.313.871.6916994542.65057213CS
      1560.9237.09677419352.483.870.970115087072.29931569CS
      260-4.05-54.36241610747.457.940.970118236453.07245229CS

      XERS - Frequently Asked Questions (FAQ)

      What is the current Xeris Biopharma share price?
      The current share price of Xeris Biopharma is $ 3.40
      How many Xeris Biopharma shares are in issue?
      Xeris Biopharma has 149,081,461 shares in issue
      What is the market cap of Xeris Biopharma?
      The market capitalisation of Xeris Biopharma is USD 511.35M
      What is the 1 year trading range for Xeris Biopharma share price?
      Xeris Biopharma has traded in the range of $ 1.69 to $ 3.87 during the past year
      What is the PE ratio of Xeris Biopharma?
      The price to earnings ratio of Xeris Biopharma is -8.14
      What is the cash to sales ratio of Xeris Biopharma?
      The cash to sales ratio of Xeris Biopharma is 3.09
      What is the reporting currency for Xeris Biopharma?
      Xeris Biopharma reports financial results in USD
      What is the latest annual turnover for Xeris Biopharma?
      The latest annual turnover of Xeris Biopharma is USD 163.91M
      What is the latest annual profit for Xeris Biopharma?
      The latest annual profit of Xeris Biopharma is USD -62.26M
      What is the registered address of Xeris Biopharma?
      The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Xeris Biopharma website address?
      The website address for Xeris Biopharma is www.xerispharma.com
      Which industry sector does Xeris Biopharma operate in?
      Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NXUNXU Inc
      $ 1.98
      (713.48%)
      		456.34M
      WATTEnergous Corporation
      $ 1.538
      (274.03%)
      		167.83M
      INTZIntrusion Inc
      $ 5.485
      (153.94%)
      		115.21M
      JDZGJIADE Ltd
      $ 1.51
      (115.65%)
      		7.54M
      CYNCYNGN Inc
      $ 1.205
      (91.91%)
      		62.14M
      ABPAbpro Holdings Inc
      $ 2.1215
      (-52.75%)
      		1.52M
      TRAWTraws Pharma Inc
      $ 7.77
      (-42.10%)
      		907.82k
      SHOTWSafety Shot Inc
      $ 0.122005
      (-32.33%)
      		1.1k
      LITMSnow Lake Resources Ltd
      $ 1.155
      (-27.81%)
      		45.08M
      BITSGlobal X Blockchain and Bitcoin Stratagy ETF
      $ 66.74
      (-24.56%)
      		9.05k
      NXUNXU Inc
      $ 1.98
      (713.48%)
      		456.34M
      VINCVincerx Inc
      $ 0.3288
      (69.48%)
      		305.17M
      XTIAXTI Aerospace Inc
      $ 0.0399
      (1.01%)
      		185.44M
      WATTEnergous Corporation
      $ 1.535
      (273.30%)
      		167.84M
      SMXSMX Security Matters Public Company
      $ 0.621201
      (75.68%)
      		153.31M

      XERS Discussion

      View Posts
      81vette 81vette 2 weeks ago
      8 month trend is tremendously strong in this market!!
      👍️0
      Firestorm22 Firestorm22 1 month ago
      Seems a lot like all the hyped pump and dump stocks. I see the same hype from people posting but no results…..hmmmmmm
      👍️0
      Rkrocks Rkrocks 2 months ago
      Monk things starting to take shape
      👍️0
      Pascal2 Pascal2 6 months ago
      We need to rebound to 3 first. Back to level. Normal And to 4. Is possible ..
      👍️0
      Monksdream Monksdream 9 months ago
      XERS under $3
      👍️0
      StocksNcash StocksNcash 9 months ago
      Still here👍
      👍️0
      Frankestin Frankestin 10 months ago
      We are ready?🙏
      👍️0
      Nadendla Nadendla 10 months ago
      ya..:)
      👍️0
      StocksNcash StocksNcash 10 months ago
      Your welcome
      👍️0
      buccaneer1961 buccaneer1961 10 months ago
      Thankyou!
      👍️0
      StocksNcash StocksNcash 10 months ago
      Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      XERS...3.29 BREAK OUT COMING UP
      👍️0
      buccaneer1961 buccaneer1961 10 months ago
      Green lately..whats the catalysts?
      👍️0
      StocksNcash StocksNcash 10 months ago
      Buy hold and don’t look back$$$$$
      👍️0
      Monksdream Monksdream 11 months ago
      XERS new 52 week high
      👍️0
      Rkrocks Rkrocks 2 years ago
      Let’s hope to break 3.00 soon
      👍️0
      price_and_volume price_and_volume 3 years ago
      Izzy Englander likes $XERS...

      https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
      👍️0
      mess124 mess124 3 years ago
      Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

      Strongbridge vanished and XERS showed up.


      Thank you
      👍️0
      Elgordo84 Elgordo84 3 years ago
      Yes indeed
      👍️0
      alchemytrader alchemytrader 3 years ago
      Nice catch in the low 2.00s.
      👍️0
      Elgordo84 Elgordo84 3 years ago
      Goodluck to all the Longs!
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Ramping up for sure.
      👍️0
      Elgordo84 Elgordo84 3 years ago
      I like what I see here!

      Looks like a Trend reversal

      Great with patience!

      Let’s go $XERS

      #EG84
      👍️0
      ahimsa27 ahimsa27 3 years ago
      PDUFA New Years ?
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
      👍️0
      ezyE ezyE 3 years ago
      Can we make it rain here?
      👍️0
      kzivann kzivann 3 years ago
      Premarket action .. nice news.


      XERS
      👍️0
      tknuncle tknuncle 3 years ago
      Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

      https://www.otcmarkets.com/stock/SLS/security

      Thanks for any feed back. Much appreciated
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Item 5.

      Ownership of 5 Percent or Less of a Class. If this statement is being
      filed to report the fact that as of the date hereof the reporting person
      has ceased to be the beneficial owner of more than 5 percent of the
      class of securities, check the following [ X ].
      👍️0
      $Money Bags$ $Money Bags$ 3 years ago
      Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
      👍️0
      Modlich Modlich 4 years ago
      Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
      and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Nom nom nom bring the gains.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
      👍️0
      harr449 harr449 4 years ago
      Recent announcement of deal caused PT to go from $14 to $9.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      You guys enjoying the start of this nice run?
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Delicious.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
      👍️0
      I Dump I Dump 4 years ago
      Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Conversions on this are still brutal. Float is low, one day she breaks the chains.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Must be looming conversions. Company events looking good.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Must be looming conversions. Company events looking good.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Good news out after hours. $$$
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
      👍️0
      mte1955 mte1955 4 years ago
      My thoughts exactly. Hopefully the dance continues for this and many other stocks.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
      👍️0
      $Money Bags$ $Money Bags$ 4 years ago
      Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
      👍️0
      Termite7 Termite7 4 years ago
      Good chart!!!
      👍️0
      trustbutverifyit trustbutverifyit 4 years ago
      Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
      👍️0

      Your Recent History

      NASDAQ
      XERS
      Xeris Biopharma
      BIT
      UIG158
      Unicredit Bank
      BIT
      S32590
      Societe Generale Effekten
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads